
Jeff Lee, PharmD
Advertisement
Articles by Jeff Lee, PharmD

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
3
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
4
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
5